USANA Health Sciences, Inc.
USNA
$33.08
$0.120.36%
09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -6.52% | -39.67% | -10.04% | 31.04% | -23.99% |
Total Depreciation and Amortization | 7.75% | 10.91% | -2.68% | -7.25% | -4.90% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -3.07% | 21.68% | -20.04% | -28.15% | 198.30% |
Change in Net Operating Assets | 970.24% | 44.95% | 43.17% | -128.46% | -88.72% |
Cash from Operations | 32.83% | -16.34% | 37.79% | -35.69% | -23.66% |
Capital Expenditure | -64.99% | 25.99% | -51.92% | -122.95% | 59.39% |
Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -33.33% | -100.00% |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -70.20% | 31.55% | -- | -- |
Cash from Investing | -60.80% | -963.69% | -20.43% | -123.10% | 59.37% |
Total Debt Issued | -- | -79.47% | -- | -- | -100.00% |
Total Debt Repaid | -- | -96.80% | -- | -- | 100.00% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | 99.32% | 43.64% | -336.32% | 10.67% | -26,356.82% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 99.33% | -2,360.00% | -273.43% | 538.67% | -26,356.82% |
Foreign Exchange rate Adjustments | 341.38% | 79.96% | -582.15% | 3.54% | 75.38% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 373.21% | -11.06% | -130.37% | -42.81% | -57.87% |